MENLO PARK, Calif.--(BUSINESS WIRE)--Enable Medicine, a leader in AI for biological research and drug discovery, announced today it will present a number of poster presentations at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting being held November 1-5, 2023, in San Diego, California.

"We are excited to showcase the capabilities of Enable Medicine’s platform in analyzing pathology and other omic data to improve our understanding of cancer biology and predict potential treatment response in patients," said Sunil Bodapati, CEO, Enable Medicine. “These study results will advance our understanding of the tumor microenvironment and empower researchers to use our comprehensive maps of disease biology to understand how the organization of cells impact disease pathology, progression, and therapeutic response.”

Title: From images to insights: Deep spatial profiling reveals disease and treatment biomarkers

Abstract Number: #95

Date / Time: November 3rd, 12–1:30 p.m. PDT & November 4th, 11:55–1:25 p.m. PDT

Location: Exhibit Halls A and B1 – San Diego Convention Center

Title: Integrative spatial multi-omics analysis of NSCLC tumor microenvironment identifies key features associated with response to immune checkpoint inhibitor therapy

Abstract Number: #222

Date / Time: November 3rd, 12–1:30 p.m. PDT & November 4th, 11:55–1:25 p.m. PDT

Location: Exhibit Halls A and B1 – San Diego Convention Center

Title: emObject: domain specific data abstraction for spatial omics

Abstract Number: #899

Date / Time: November 3rd, 12–1:30 p.m. PDT & November 4th, 11:55–1:25 p.m. PDT

Location: Exhibit Halls A and B1 – San Diego Convention Center

Title: Quantitative cell morphology featurization in multiplexed immunofluorescence images reveals tumor subtypes in cancer microenvironments

Abstract Number: #1290

Date / Time: November 3rd, 12–1:30 p.m. PDT & November 4th, 11:55–1:25 p.m. PDT

Location: Exhibit Halls A and B1 – San Diego Convention Center

Title: A machine learning toolkit for automated processing of multiplexed immunofluorescence images

Abstract Number: #1302

Date / Time: November 3rd, 12–1:30 p.m. PDT & November 4th, 11:55–1:25 p.m. PDT

Location: Exhibit Halls A and B1 – San Diego Convention Center

Title: Polarity measurements from multiplex imaging suggest immune cell activation

Abstract Number: #1314

Date / Time: November 3rd, 12–1:30 p.m. PDT & November 4th, 11:55–1:25 p.m. PDT

Location: Exhibit Halls A and B1 – San Diego Convention Center

Title: Identification and generalization of tissue structures with spatial cellular graph partitioning

Abstract Number: #1315

Date / Time: November 3rd, 12–1:30 p.m. PDT & November 4th, 11:55–1:25 p.m. PDT

Location: Exhibit Halls A and B1 – San Diego Convention Center

The full abstracts will be released on the SITC website on Tuesday, October 31, 2023 at 9:00 a.m. ET.

https://www.businesswire.com/news/home/20231030900610/en/Enable-Medicine-to-Present-Poster-Presentations-at-the-Society-for-Immunotherapy-of-Cancer-SITC-2023-Annual-Meeting

About Enable Medicine

Enable Medicine harnesses the revolutionary capabilities of AI to provide cutting-edge insights into biology and medicine. Our platform finds biological signatures relevant to the asset or indication. Our global network of partners leverage the platform to guide target discovery, identify new biomarkers, and develop optimal treatment strategies. Enable Medicine is headquartered in Menlo Park, CA. Learn more at: www.enablemedicine.com. Follow us @EnableMedicine.

Full Name
Title
Adrian is a product manager at Enable. He completed his PhD in Biochemistry from Dalhousie University. During his postdoc at MIT, Adrian discovered a passion for building things in teams. Since then he has worked at a number of biotech startups in product roles. In his free time, he likes to explore, see new places, and keep active.
Next posts
Back to press
Have a question?
Interested in collaborating with us to leverage the latest in high-parameter biological tools and uncover new biology, have a question about our platform, or something else? Please reach out!
Contact us